STEPHANIE HATTAWAY: Open Payments
NPI 1114433166 · ANDALUSIA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,041 in 54 payments from 12 companies in 2025. Trend: 2023 $163 · 2024 $572 · 2025 $1,041
Food & beverage: $1,022Education: $19
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $224 |
| Novo Nordisk Inc | 10 | $183 |
| PFIZER INC. | 13 | $151 |
| ABBVIE INC. | 7 | $138 |
| Otsuka America Pharmaceutical, Inc. | 3 | $81 |
| Alpha Cognition USA, Inc. | 1 | $76 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: MOUNJARO, Ozempic, NURTEC ODT, REXULTI, Zunveyl, VRAYLAR, QULIPTA, BREZTRI.
Industry payments across AL — which companies pay providers there.
